Silk Road Medical Inc. announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. This launch expands upon the company's prior ENROUTE TranscarOTid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy. TCAR is a minimally invasive, surgical procedure designed to provide best-in-class stroke protection while minimizing adverse events.

The ENROUTE Transcarotaid Stent System is the only commercially available transcarotid stent system indicated for patients at high risk and standard risk for adverse events from carotid endarterectomy (CEA). The ENROUTE Trans carotid Stent System features an optimized cell design balancing lesion coverage and anatomical consistency for long-term plaque stabilization. The stent system was purpose-built for TCAR with a short delivery system for ergonomic and precise stent delivery.